« Actelion May Fetch $9.8 Billion in Amgen Deal | Main | Roche Cuts in US and West; Grows in China »

11/18/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f60aeb59970b

Listed below are links to weblogs that reference Merck Scores Coup with its CETP Inhibitor at AHA Meeting:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

In the Pipeline provided more commentary around the history of CETP inhibitors and suggests that Merck's results, while good so far, still need to make it through a large clinical trial - which won't be complete until 2015 so they are not out of the woods yet.
http://pipeline.corante.com/archives/2010/11/19/mercks_cetp_compound_still_alive_but_the_big_fun_awaits.php

bigredbruce

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada